BIOSPAIN 2025
BIOSPAIN is one of the most prominent biotechnology events in Europe and one of the largest in the world, both in terms of the number of one-to-one meetings and the participation of companies from around the globe. More than one-third of the attendees come from outside the country. This year, it was held in Barcelona, one of the leading biotechnology clusters in Southern Europe and one of the most vibrant and innovative cities in the world.
07.10.2025
09.10.2025
Fira de Barcelona – Montjuïc
AseBio
Generalitat de Catalunya, Biocat and Ajuntament de Barcelona
BIOSPAIN, held at Fira de Barcelona – Montjuïc, took place from October 7 to 9, 2025, with the aim of promoting innovation, investment, collaboration, and the creation of new business opportunities in the sector. Over the course of these three days, the congress hosted conferences and networking sessions, offered exhibition spaces, and facilitated one-to-one meetings to foster connections between investors, startups, and research institutions — strengthening Catalonia’s leadership on the international stage.
This twelfth edition closed with record-breaking figures, surpassing those of the 2023 event. More than 2,400 attendees from 1,065 organizations across 34 countries took part over the three days at Fira de Barcelona. In addition, the event brought together 140 investors from 76 national and international investment firms and featured 250 exhibitors. Altogether, over 4,500 meetings were held, further consolidating BIOSPAIN as the leading event for the biotechnology sector at a global level.
Barcelona, The BioRegion of Catalonia Pavilion
Biocat, with the support of the Government of Catalonia and the Barcelona City Council, led for the second consecutive year the Barcelona, The BioRegion of Catalonia Pavilion, a key space within the BIOSPAIN framework aimed at enhancing the visibility and international projection of the most cutting-edge initiatives from the BioRegion of Catalonia.
This year’s edition concluded with the announcement of Bilbao as the new host city for 2026, where the congress will take place from September 29 to October 1. Additionally, the event has been revamped to move away from a biennial format and will now be held annually, with upcoming editions set to take place in the city of Barcelona in 2027 and 2029.
Participating startups
Featured Activities
Catalyzing 5P Health: Where Are We Regarding Data?
Tuesday, 07/10/2025 3:15 PM - 4:00 PM
Catalyzing 5P Health means unlocking the power of data for predictive, preventive, ersonalized, participatory, and population-based care. At Biospain, this panel will explore where we stand in health data sharing and where we must go. Hospitals hold vast clinical data but face barriers in interoperability and governance. Clusters connect ecosystems, aligning standards and trust across stakeholders. Industry actors bring innovation in pharma, medtech, and platforms, but need secure access to real-world data.
AI factories turn data into intelligence, yet depend on quality, diversity, and transparency. The discussion will highlight the European Health Data Space (EHDS), FAIR principles, and GDPR. We will examine how to balance innovation with privacy, ethics, and public trust. Real-world data, data altruism, and federated systems will be key themes. Join us to learn how data can truly catalyse the future of 5P Health.
Sponsored by:
- Biocat and Innomedcatalyst
Moderator:
- Montse Daban, Director of Strategic Analysis and International Relations. Biocat
Speakers:
- Simona Giardina, PhD Life Sciences Scientific Coordination Officer For Data Management. Barcelona Supercomputing Center
- Xavier Conill, General Director of the AECT. Hospital de Cerdanya
- Samuel Giacomucci, Head of IT for EUCAN and International Rare Diseases. Alexion
- Marco di Donato, Policy and Project Manager. EUREGHA
Science Meets Capital: De-Risking Early Biotech to Unlock Investment
Wednesday 8/10/2025- 11:30 AM - 12:15 PM
Moderator:
- Robert Fabregat, CEO. Biocat
Speakers:
- Dr Merce De Frias Sánchez, COO. Ona Therapeutics, SL
- Mr Thomas Harth, Partner. Ysios Capital
- Dr Raymond Donninger, Senior Director Commercial Development. Lonza
Sharing Gains and Risks: The Next Frontier in ATMPs
Wednesday, 08/10/2025 3:15 PM - 4:00 PM
This roundtable will address the main challenges in the adoption and reimbursement of advanced therapies within public healthcare systems, with a focus on regulatory complexity, budgetary constraints, and the uncertainties surrounding clinical and economic evidence. It will explore the risks to be assumed by key stakeholders — including HTA bodies, policymakers, clinicians, regulators, and industry — as well as innovative reimbursement models such as risk-sharing agreements and outcome-based payments, and public-private collaboration strategies aimed at ensuring equity and system sustainability
Organized by:
- Biocat
Moderator:
- Robert Fabregat, CEO. Biocat
Speakers:
- David Morrow, Scientific lead Advanced Therpies. EATRIS
- Sandra García-Armesto, Director. AQuAS
- Pablo Méndez, Head of Market Access & Public Affairs, Iberia. CSL Behring
- Stefanos Theoharis, CEO. OneChain Immunotherapeutics
- Lidia Cánovas, General Manager Regulatory Affairs. Asphalion S.L.
Orphan Drugs and Legislative Changes: Key Factors to Protect Innovation and Advance Equity
Wednesday, 08/10/2025 – 4:00 PM to 5:00 PM
Moderator:
- Montse Daban, Director of Strategic Analysis and International Relations. Biocat
Speakers:
- Jordi Cruz, Trustee. FEDER Foundation (Spanish Federation of Rare Diseases) / Director. MPS-Lysosomal Association
- Gonzalo de Miquel, Vice President of Global Clinical Development. Alexion AZ Rare Diseases / Ambassador. AZ Global Hub
- Prof. Francisco Zaragozá, Professor of Pharmacology. University of Alcalá / Member. Legislative Observatory on Rare Diseases and Orphan Drugs
- Dr. Joan Comella, Director of Research, Innovation and Learning. Sant Joan de Déu Hospital, Barcelona
Organizer:
Host Committee:
